Insider · CIK 0001624830

Ryan Charles S.

Reports to the SEC for 5 companies · PARAMUS, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001624830

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	IRLAIRulya Therapeutics Inc. · Employee Stock Option (Right to Buy)A Award	President	AAward	+200K sh	—	—	200,000
2025-06-18	IRLAIRulya Therapeutics Inc.A Award	President	AAward	+7,548 sh	$1.20	+$9,057.6	130,009
2025-06-18	IRLAIRulya Therapeutics Inc. · WarrantsA Award	President	AAward	+7,548 sh	$0.13	+$943.5	7,548
2025-01-28	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	President	AAward	+300K sh	—	—	300,000
2024-08-20	IRLAIRulya Therapeutics Inc.P Purchase	President	PPurchase	+48.4K sh	$0.65	+$31.5K	122,461
2024-02-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	President	AAward	+145K sh	—	—	145,000
2023-09-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	President	AAward	+545K sh	—	—	545,000
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−158K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−79.1K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−150K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−131K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−40K sh	—	—	0
2020-11-24	Neurotrope, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2019-12-13	Neurotrope, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+131K sh	—	—	130,680
2019-05-17	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+175K sh	—	—	175,435
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+15K sh	—	—	15,000
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+20K sh	—	—	20,000
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionD Disposition to Issuer	Director	DDisposition to Issuer	−46K sh	—	—	0
2019-03-25	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+46K sh	—	—	46,000
2019-03-25	BRTXBioRestorative Therapies, Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−100K sh	—	—	0
2019-03-25	BRTXBioRestorative Therapies, Inc. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2019-03-25	BRTXBioRestorative Therapies, Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2019-03-25	BRTXBioRestorative Therapies, Inc. · Stock OptionA Award	Director	AAward	+75K sh	—	—	75,000
2019-01-22	Neurotrope, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+150K sh	—	—	150,000
2018-12-14	Neurotrope, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+79.1K sh	—	—	79,097
2018-10-29	BRTXBioRestorative Therapies, Inc. · Stock OptionA Award	Director	AAward	+75K sh	—	—	75,000
2018-10-17	BNBXBNB PLUS CORP. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2018-10-17	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+12.8K sh	—	—	12,778
2018-03-15	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+63.9K sh	—	—	63,919
2018-03-15	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+7,204 sh	—	—	7,204
2017-12-14	Neurotrope, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+158K sh	—	—	157,918
2017-06-28	BNBXBNB PLUS CORP.A Award	Director	AAward	+14.2K sh	$1.76	+$25K	14,205
2017-06-23	BRTXBioRestorative Therapies, Inc. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2017-03-01	BRTXBioRestorative Therapies, Inc.A Award	Director	AAward	+26.7K sh	$3.00	+$80K	42,917
2017-03-01	BRTXBioRestorative Therapies, Inc. · WarrantA Award	Director	AAward	+26.7K sh	—	—	26,667
2017-02-14	BRTXBioRestorative Therapies, Inc. · OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2017-02-14	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+15K sh	—	—	15,000
2017-02-14	BRTXBioRestorative Therapies, Inc. · OptionD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2017-02-14	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+20K sh	—	—	20,000
2016-12-20	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+44.8K sh	—	—	44,787
2016-06-10	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+46K sh	—	—	46,000
2015-12-22	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+20K sh	—	—	20,000
2015-12-21	BNBXBNB PLUS CORP. · Stock Option (right to buy)A Award	Director	AAward	+32.5K sh	—	—	32,455
2015-12-07	BRTXBioRestorative Therapies, Inc.P Purchase	Director	PPurchase	+6,250 sh	$4.00	+$25K	16,250
2015-12-07	BRTXBioRestorative Therapies, Inc. · WarrantP Purchase	Director	PPurchase	+6,250 sh	—	—	6,250
2015-05-08	BRTXBioRestorative Therapies, Inc.P Purchase	Director	PPurchase	+200K sh	$0.25	+$50K	200,000
2015-05-08	BRTXBioRestorative Therapies, Inc. · WarrantP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2015-04-06	BRTXBioRestorative Therapies, Inc. · OptionA Award	Director	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Jan 234
Ryan Charles S.0000912282-26-000120
SEC(opens sec.gov)
Jun 234
Ryan Charles S.0000912282-25-000696
SEC(opens sec.gov)
Feb 114
Ryan Charles S.0001415889-25-003615
SEC(opens sec.gov)
Aug 224
Ryan Charles S.0001415889-24-022054
SEC(opens sec.gov)
Feb 24
Ryan Charles S.0001415889-24-002380
SEC(opens sec.gov)
Sep 64
Ryan Charles S.0001209191-23-048483
SEC(opens sec.gov)
Dec 34
Ryan Charles S.0001104659-20-132153
SEC(opens sec.gov)
Nov 274
Ryan Charles S.0001104659-20-130079
SEC(opens sec.gov)
Dec 164
Ryan Charles S.0001104659-19-073078
SEC(opens sec.gov)
May 214
Ryan Charles S.0001144204-19-027507
SEC(opens sec.gov)
Mar 254
Ryan Charles S.0001567619-19-007601
SEC(opens sec.gov)

Companies

Address

SOUTH TOWER, 140 E RIDGEWOOD AVENUE, SUITE 415

PARAMUS, NJ, 07652